Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer Susceptibility

We recently reported that a sequence variant in the cell-cycle–checkpoint kinase CHEK2 (CHEK2 1100delC) is a low-penetrance breast cancer–susceptibility allele in noncarriers of BRCA1 or BRCA2 mutations. To investigate whether other CHEK2 variants confer susceptibility to breast cancer, we screened...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schutte, Mieke, Seal, Sheila, Barfoot, Rita, Meijers-Heijboer, Hanne, Wasielewski, Marijke, Evans, D. Gareth, Eccles, Diana, Meijers, Carel, Lohman, Frans, Klijn, Jan, van den Ouweland, Ans, Futreal, P. Andrew, Nathanson, Katherine L., Weber, Barbara L., Easton, Douglas F., Stratton, Michael R., Rahman, Nazneen
Format: Artigo
Idioma:Inglês
Publicat: The American Society of Human Genetics 2003
Matèries:
Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1180332/
https://ncbi.nlm.nih.gov/pubmed/12610780
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars